SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat is gaining attention, with community members highlighting its recent launch on Phantom Wallet and potential for significant growth. The conversation revolves around 'moon' and 'rocket' references suggesting possible rapid price appreciation. Some users are pointing out potential scam risks.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

GBTC is trending as Bitcoin flirts with all-time highs, driving discussion about potential breakouts and future price targets. Community members are closely watching technical indicators and whale activity, anticipating a continued uptrend. Broader market factors, like potential shifts from gold to Bitcoin and the impact of government policies, are also being considered.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following FDA approval of their leukemia drug, Revuforj, though a boxed warning regarding potentially fatal side effects tempers initial enthusiasm. The community is debating the impact of the safety label, comparing it to competitor Kura Oncology's profile, and weighing whether the market is overreacting given the drug's efficacy and the unmet need it addresses. Some believe the dip is a buying opportunity, while others worry about potential risks and side effects.

Moo Deng

MOODENG is trending as traders discuss recent price volatility and potential for a breakout. Community members are debating entry points, with some pointing to technical analysis patterns, while others express skepticism, citing its meme coin status and past performance. The coin's listing on Robinhood and upcoming birthday are also being mentioned as potential catalysts.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community anticipates the Kraken listing and speculates on potential Coinbase and Binance listings. Discussions revolve around the project's potential for mainstream adoption, partnerships with NBA and NHL, and the upcoming Super App. Some users are debating the project's legitimacy and comparing it to XRP.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as investors anticipate potential new contracts following its Gen AI Summit, where over 300 AI executives were in attendance. The community speculates about a possible TikTok deal and expansion into government contracts, driving institutional interest. Bullish sentiment is fueled by analysts increasing price targets, though some caution against excessive speculation and highlight the company's AI-driven growth amid rising competition.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid discussions about a potential recall of specific lots and the impact on revenue, with community members analyzing the company's response and comparing it to similar situations with competitors. Some traders are interpreting recent stock sales by the CEO, alongside an FDA safety notice, while others suggest potential manufacturing issues. Despite concerns, many community members express confidence in the company's long-term growth and potential for a buyback.

AABG Token

AABB is trending as investors discuss the potential for a share squeeze and look forward to upcoming news regarding the wallet, dividends, and a potential legal action against market manipulation. Community members express confidence in the company's progress and are accumulating shares while awaiting key catalysts. The rise in gold and silver prices is also fueling optimism for AABB's future.

XDC Network is an enterprise-ready hybrid Blockchain technology company optimized for international trade and finance. The XDC Network is powered by the native coin called XDC. The XDC protocol is architected to support smart contracts, 2000TPS, 2seconds transaction time, KYC to Masternodes (Validator Nodes). The XDC Chain (XinFin Digital Contract) uses XinFin Delegated Proof of Stake (XDPoS), with the intending to create a ‘highly-scalable, secure, permission, and commercial grade’ blockchain network. XinFin mainnet token XDC and also creates an opportunity to utilize the XinFin’s real-world use-cases such as TradeFinex.org, helps small and medium businesses or institutions originate their own financial requirements in a digital, fully structured manner so that they can distribute it to the bank or non-bank funders themselves using a common distribution standard.

XinFin Network

XDC is trending as the community discusses its potential for real-world asset tokenization and adoption in trade finance, with some highlighting its regulatory alignment and institutional partnerships. Despite some frustration over price stagnation, many believe XDC is a sleeping giant poised for significant growth, particularly with upcoming catalysts and infrastructure developments. Conversations also mention potential listings on major exchanges and comparisons to other ISO 20022 compliant cryptocurrencies.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx ($INBX) is trending due to positive updates on its INBRX-101 drug for AATD, specifically regarding a functional alpha-1 antitrypsin serum levels endpoint, leading to speculation about accelerated FDA approval; the community is actively discussing its potential and analyst target price increase. Some traders are noting its low float and potential for a short squeeze, while others are wary of a possible upcoming offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aehr Test Systems, Inc. (AEHR) shares fell nearly 17% in Monday’s extended session after the semiconductor testing solutions company reported a year-over-year drop in its first-quarter revenue and failed to issue formal guidance, citing tariff-related uncertainty.On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/AEHR">Aehr Test Systems stock</a> remained ‘bearish’ (35/100) as of late Monday, while the message volume was ‘extremely high.’<figure class="image"><img style="aspect-ratio:615/57;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_06_at_10_18_25_PM_png_b187da5bec.webp" alt="Screenshot 2025-10-06 at 10.18.25 PM.png" width="615" height="57"><figcaption>AEHR sentiment and message volume as of 10:15 p.m. ET, Oct. 6 | source: Stocktwits</figcaption></figure>The Fremont, California-based company’s revenue for the first quarter of the fiscal year 2026 fell to $11 million from $13.1 million in the year-ago period, although it exceeded the Fiscal.ai-compiled consensus of $10.77 million. The adjusted earnings per share (EPS) were $0.01, down significantly from the year-ago’s $0.07. &nbsp;Analysts, however, were bracing for only break-even results. Bookings totaled $11.4 million for the quarter, and backlog as of Aug. 29 was $15.5 million.&nbsp;President and CEO Gayn Erickson said, “We are pleased with the start to this fiscal year, with revenues across several market segments and momentum in sales and customer engagements in both wafer-level and packaged part test and burn-in of artificial intelligence (AI) processors.” He noted that the company’s lead production customer, a hyperscaler, has multiple follow-on volume production orders for its new Sonoma ultra-high-power packaged part burn-in systems.&nbsp;Looking ahead, Erickson said he expects nearly all of the company’s served markets to see order growth in the fiscal year, with silicon carbide growth expected to strengthen further in the next fiscal.“Although we remain cautious due to ongoing tariff-related uncertainty and are not yet reinstating formal guidance, we are confident in the broad-based growth opportunities ahead across AI and our other markets.”A bearish user lamented the company's cash burn, calling it “brutal.” They noted that free cash flow has been negative for seven out of the last eight quarters and that in the first quarter alone, the company burned $6.8 million. “At this rate, they’ll need to raise cash soon,” they said.<stembedurl>https://stocktwits.com/AnonMav/message/631243851</stembedurl>Another watcher called the company an “overhyped” name that is failing to live up to expectations. They see more room for the stock to fall.<stembedurl>https://stocktwits.com/BIG_BEAR_/message/631242779</stembedurl>For the year-to-date period, Aehr Test System stock has gained over 90%. Wall Street analysts, however, don’t share traders’ optimism. According to Koyfing, the consensus price target for the stock is $16.50, implying nearly 50% downside from Monday’s close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-says-happy-to-work-with-democrats-on-failed-healthcare-policies/ch62HkbR3gz">Trump Says He's 'Happy To Work' With Democrats On 'Failed' Healthcare Policies, But Calls To End Government Shutdown</a>

In this photo illustration, the AEHR Test Systems logo is displayed on a smartphone screen, on April 6, 2025, in Chongqing, China. 

Why Aehr Test Systems Stock Tumbled Nearly 17% In After-Hours

Looking ahead, CEO Gayn Erickson said he expects nearly all of the company’s served markets to experience order growth in the fiscal year, with silicon carbide growth expected to strengthen further in the next fiscal year.

Equity

Looking ahead, CEO Gayn Erickson said he expects nearly all of the company’s served markets to experience order growth in the fiscal year, with silicon carbide growth expected to strengthen further in the next fiscal year.


Camtek (CAMT) Moves 13.7% Higher: Will This Strength Last?

Camtek (CAMT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Aehr Test Systems (AEHR), which makes equipment used to test computer chips, announced on Tuesday that it has landed an order from a major AI chip company to evaluate its wafer-level testing system.The evaluation, a paid contract, includes the development of a customized WaferPak contactor, tailored for 300mm wafers, as well as the creation of a production-level WLBI (wafer-level burn-in) testing program.&nbsp;<a href="https://stocktwits.com/symbol/AEHR">Aehr Test Systems’ stock</a> traded over 4% higher by Tuesday mid-morning. On Stocktwits, retail sentiment toward the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day. Meanwhile, message volume shifted to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:938/110;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_104919_png_bf78429182.webp" alt="AEHR’s Sentiment Meter and Message Volume as of 10:35 a.m. ET on Aug.26, 2025 | Source: Stocktwits" width="938" height="110"><figcaption>AEHR’s Sentiment Meter and Message Volume as of 10:35 a.m. ET on Aug.26, 2025 | Source: Stocktwits</figcaption></figure>The stock saw a 1,473% increase in user message count over the last seven days. A Stocktwits user called the latest order ‘huge’ and said that&nbsp;big money orders will follow.<stembedurl>https://stocktwits.com/ednorton/message/626556012</stembedurl>The application testing and burn-in process will be executed at Aehr’s headquarters in Fremont, California, using its FOX-XP platform. The platform is built to handle demanding power and thermal requirements. As part of the evaluation, the system will be used to deliver extremely high electrical currents, measured in hundreds of amps, across entire wafers of the AI supplier’s processors.&nbsp;“The evaluation will also highlight the advantages of WLBI over traditional package-level burn-in, particularly for devices such as advanced AI processors, which are often packaged along with high-bandwidth memory chips (HBM) as well as other compute processors,” said President and CEO Gayn Erickson.The company distinguishes itself in the semiconductor equipment space by offering solutions for both wafer-level and packaged part burn-in. While the FOX-XP targets wafer-level testing, its&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aehr-test-stock-surges/chssAKORd16">Sonoma systems</a> provide burn-in solutions post-packaging, enabling chip manufacturers to test devices at different stages of production.Aehr Test Systems' stock has gained over 54% in 2025 and over 71% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/meta-teen-safety-push-backed-by-paid-supporters-investigation-reveals/chsHUmhRdjZ">Meta’s Teen Safety Push Backed By Paid Supporters, Investigation Reveals: Retail’s Not Impressed</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the AEHR Test Systems logo is displayed on a smartphone screen.

Aehr Stock Gains On AI Chip Evaluation Deal: Retail Believes Big Money Orders Will Follow

The evaluation, a paid contract, includes the development of a customized WaferPak contactor, tailored for 300mm wafers, as well as the creation of a production-level WLBI (wafer-level burn-in) testing program. 

Implied Volatility Surging for Aehr Test Systems Stock Options

Investors need to pay close attention to AEHR stock based on the movements in the options market lately.

U.S. equities were mixed in Monday’s midday trade as Wall Street awaits further cues after the Dow Jones Industrial Average (DJIA) set a new record in the previous session. Investor focus is now on AI bellwether Nvidia Corp.’s (NVDA) second-quarter (Q2) results.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was down 0.06% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq, gained 0.15%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which mirrors the Dow Jones Industrial Average, fell 0.51%.Here are the top stocks making the biggest moves in Monday’s midday trade:<a href="https://stocktwits.com/symbol/OPEN">Opendoor Technologies Inc. (OPEN)</a>Opendoor shares soared over 13% on Monday and emerged as the top trending ticker on Stocktwits. Investors&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/opendoor-back-on-meme-stock-hype-train-powell-s-rate-cut-hints-ceo-search-have-retail-bulls-all-aboard/chss9hrRdKq">sounded optimistic</a> following Federal Reserve Chair Jerome Powell’s Jackson Hole speech, which raised hopes of an interest rate cut in September, thereby boosting prospects for the housing sector. Opendoor is a real estate buyer and seller.<a href="https://stocktwits.com/symbol/OPEN">OPEN stock</a> is up 258% year-to-date.<a href="https://stocktwits.com/symbol/AEHR">Aehr Test Systems Inc. (AEHR)</a>Aehr Test Systems shares surged over 37% after the company announced that it received an order for six Sonoma ultra-high-power packaged part burn-in systems from its lead production artificial intelligence (AI) processor customer.<a href="https://stocktwits.com/symbol/AEHR">AEHR stock</a> is up 49% year-to-date.<a href="https://stocktwits.com/symbol/INTC">Intel Corp. (INTC)</a>Intel shares gained over 1% in Monday’s midday trade after the Trump administration announced the terms of its equity investment in the chipmaker after markets closed on Friday. White House Economic Advisor on Monday said the Trump administration&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/kevin-hassett-us-stake-intel-like-down-payment-on-sovereign-wealth-fund/chssoWyRd1r">struck a deal</a> with the chipmaker to make it easier for the company to get the CHIPS Act funding.<a href="https://stocktwits.com/symbol/INTC">INTC stock</a> is up 25% year-to-date.<a href="https://stocktwits.com/symbol/TLRY">Tilray Brands Inc. (TLRY)</a>Tilray shares surged over 17% in Monday’s midday trade after Jefferies raised its price target for the cannabis company to $2 from $1.5, according to The Fly. The firm cited President Donald Trump’s interest in rescheduling marijuana from Schedule I to Schedule III, stating that it opens the door to broader access in the U.S., and Tilray has the capacity to capture the opportunity in this segment.<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> is up 1% year-to-date.<a href="https://stocktwits.com/symbol/KDG">Keurig Dr Pepper Inc. (KDG)</a>Keurig’s shares plummeted over 8% by Monday’s midday trade after the company announced that it will acquire Dutch coffee group JDE Peet’s for $18 billion.<a href="https://stocktwits.com/symbol/KDG">KDG stock</a> is up 0.3% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/jim-cramer-warns-palantir-shorts-karp-knows-all/chssA2bRd1C">Jim Cramer Warns Palantir Shorts Not To ‘Overplay Their Hand,’ Says CEO Alex Karp 'Knows All'</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Opendoor, Aehr, Intel, Tilray, Keurig: Stocks Making The Biggest Moves Today

Opendoor shares soared over 13% on Monday and emerged as the top trending ticker on the Stocktwits platform, with investors sounding optimistic following Federal Reserve Chair Jerome Powell’s Jackson Hole speech.

Aehr Test Systems Inc. (AEHR) on Monday announced a fresh batch of orders for its high-performance Sonoma systems. The order, placed by a top-tier hyperscaler focused on AI infrastructure, includes six additional units.The new systems will support high-volume production testing of AI chips and are set to be shipped from Aehr’s facility in Fremont, California, across the next two quarters.<a href="https://stocktwits.com/symbol/AEHR">Aehr Test Systems' stock</a> shot up over 32% on Monday morning. On Stocktwits, retail sentiment toward the stock jumped to ‘bullish’ from ‘bearish’ territory the previous day. Message volume shifted to ‘high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:945/112;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_25_102904_png_e676bf65ee.webp" alt="AEHR’s Sentiment Meter and Message Volume as of 10:10 a.m. ET on Aug.25, 2025 | Source: Stocktwits" width="945" height="112"><figcaption>AEHR’s Sentiment Meter and Message Volume as of 10:10 a.m. ET on Aug.25, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user lauded the new order.<stembedurl>https://stocktwits.com/Buckanator/message/626418807</stembedurl>Another user expressed optimism about the potential of the company’s test systems.<stembedurl>https://stocktwits.com/seekingyield1/message/626414562</stembedurl>“This customer is one of the premier large-scale data center providers developing its own AI processors, and they have already indicated plans to expand capacity for this initial device and add additional AI devices over the next year,” said President and CEO Gayn Erickson.Aehr’s technology gives its customers the ability to test devices individually rather than in batches, improving throughput while reducing operating costs. This architecture enables significant power density advantages, with more watts delivered per square foot compared to traditional burn-in systems.One of the key points is how Aehr eliminates the need for costly extra burn-in boards by automating device movement between JEDEC trays and sockets. This streamlined handling can save companies hundreds of thousands of dollars. The systems also use dedicated digital I/O pins per chip, allowing more flexibility in test design than legacy platforms that share drivers across devices.The systems also feature independently controlled liquid-cooled thermal sockets, ensuring optimal heat management during test and burn-in cycles. Aehr Test Systems' stock has gained over 44% in 2025 and over 61% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/verint-to-go-private-in-2-billion-deal/chssYDXRd1w">Verint To Go Private In $2B Deal With Thoma Bravo: Retail Backs The Move</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Aehr Test Stock Surges On Fresh AI Chip Orders From Top Hyperscaler: Retail Shows Optimism

The new systems will support high-volume production testing of AI chips and are set to be shipped from Aehr’s facility in Fremont, California, across the next two quarters.

Aehr Test Systems Inc. (AEHR), a provider of semiconductor test and burn-in equipment, experienced a 494% surge in Stocktwits user messages in the last 24 hours after the company secured new orders for its advanced Sonoma ultra-high-power systems.The purchase comes from a leading hyperscaler focused on volume production testing and burn-in of AI processors, said the company on Tuesday.<a href="https://stocktwits.com/symbol/AEHR">Aehr Test Systems stock</a> traded over 8% higher on Wednesday afternoon. Retail sentiment toward the stock improved to ‘extremely bullish’ (78/100) from ‘bullish’ territory the previous day amid ‘high’ message volume levels.<figure class="image"><img style="aspect-ratio:959/126;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_23_135651_png_4361e23e1d.webp" alt="AEHR’s Sentiment Meter and Message Volume as of 02.00 p.m. ET on July 23, 2025 | Source: Stocktwits" width="959" height="126"><figcaption>AEHR’s Sentiment Meter and Message Volume as of 02.00 p.m. ET on July 23, 2025 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user expressed optimism on the latest development.<stembedurl>https://stocktwits.com/Jorlev/message/621997313</stembedurl>Another user highlighted&nbsp;AEHR's ability to prove the efficacy of their products to potential new customers.<stembedurl>https://stocktwits.com/ednorton/message/622075586</stembedurl>The follow-on orders involve eight Sonoma units to be delivered over six months from Aehr’s Fremont, California, production center.&nbsp;The Sonoma units use turnkey Burn-in Modules (BIMs) with liquid-cooled temperature controls. Each BIM incorporates a custom PCB (Printed Circuit Board), socket contactor, liquid thermal assembly, and purpose-built test programs.&nbsp;They support up to 2,000 W per device, enabling high-current delivery, dynamic stress testing, and real-time output monitoring at elevated temperatures.“Aehr enables customers to perform their production burn-in screening, qualification, and reliability characterization in package form for GPUs, AI processors, CPUs, and network processors,” said President and CEO Gayn EricksonAs demand for AI chips surges, hyperscalers seek highly efficient test and burn-in platforms. Aehr’s Sonoma systems, with their advanced thermal, power, and automation features, look to cater directly to this growing industry need.Aehr Test Systems' stock has gained over 32% year-to-date and more than 22% in the last 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/can-opendoor-stay-in-the-meme-stock-race/ch8wHldR5ud">Can Opendoor Stay In The Meme Stock Race? Retail Still Wants To Load Up On The Shares</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Aehr Test Systems’ New AI Chip Orders Spark Investor Buzz: Retail Chatter Explodes Over 490% In 24 Hours

The purchase comes from a leading hyperscaler focused on volume production testing and burn-in of AI processors.

Krispy Kreme, GoPro surge as meme stock revival continues

Investing.com -- Shares of heavily shorted companies jumped in premarket trading on Wednesday as the recent meme stock revival extended to additional names.

Aehr Test Systems, Inc. (AEHR) shares fell over 20% in Wednesday’s early premarket session after the small-cap semiconductor testing solutions company announced mixed quarterly results and flagged a potential slowdown in the first quarter due to tariffs.On Stocktwits, retail sentiment toward <a href="https://stocktwits.com/symbol/AEHR">Aehr stock</a> tempered to ‘bullish’ (73/100) by early Wednesday, from the ‘extremely bullish’ stance seen a day ago. The message volume continued to be ‘extremely high.’<figure class="image"><img style="aspect-ratio:620/54;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_09_at_5_29_07_AM_png_a0a66f4b8e.webp" alt="Screenshot 2025-07-09 at 5.29.07 AM.png" width="620" height="54"><figcaption>AEHR sentiment and message volume as of 5:30 a.m. ET, July 9 | source: Stocktwits</figcaption></figure>A bullish watcher suggested they would buy the dip.<stembedurl>https://stocktwits.com/StockWits59/message/620281907</stembedurl>Another user shrugged off the near-term headwinds, expressing confidence over a new hyperscaler customer the company announced.<stembedurl>https://stocktwits.com/KiaNiro/message/620271391</stembedurl>Fremont, California-based Aehr reported an adjusted loss per share of $0.01 for the fourth quarter of the fiscal year 2025, reversing from earnings per share (EPS) of $0.84. The company clarified that the year-ago’s bottom-line results included a tax benefit.The bottom-line result was in line with the Finchat-compiled consensus estimate.Quarterly revenue fell to $14.1 million from $16.6 million in the fourth quarter of 2024, slightly below the $14.82-million consensus estimate.Bookings totaled $11.1 million, and backlog stood at $15.2 million as of May 30.&nbsp;Aehr CEO Gayn Erickson said, “Fiscal 2025 was a transformative year for Aehr Test Systems, marked by significant progress on our strategic initiatives to expand our total addressable market, diversify our customer base, and enhance our product portfolio.”“A major milestone was the successful launch and adoption of our first production wafer-level burn-in (WLBI) system specifically for artificial intelligence (AI) processors."Erickson also disclosed that one of the leading processor companies&nbsp;has requested to proceed with an evaluation for wafer-level testing of one of its current high-volume processors.The executive expressed confidence that nearly all the opportunities and market verticals Aehr serves will experience order growth in fiscal year 2026. However, he warned that the silicon carbide market could see an order decline, as customer forecasts are back-half loaded, with stronger growth expected in fiscal year 2027.Erickson also said tariffs will likely impact performance in the near term. “While we remain confident in Aehr’s long-term growth prospects, we continue to experience some timing-related delays in order placements due to tariff-related uncertainty, particularly in our first quarter,” he said, adding that the company would not reinstate specific guidance beyond what it had already stated.Aehr stock has lost about 9% year-to-date, underperforming the broader market and the tech sector.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dollar-climbs-off-multi-year-lows-as-report-unpacks-bessent-influence-on-tariff-timeline/chFUtg2R5i2">Dollar Climbs Off Multi-Year Lows As Report Unpacks Bessent’s Influence On Trump Tariff Timeline</a>

Aehr Stock Slumps 20% Premarket After CEO Flags Tariff-Induced Order Delays — Retail Clings To Bullish Stance

Quarterly revenue fell to $14.1 million from $16.6 million in the fourth quarter of 2024, slightly below the $14.82-million consensus estimate.

Is Aehr Test Systems (AEHR) A 'Buy' Ahead of Fiscal Q4 Earnings Announcement?

Aehr Test Systems exceeded the mark during the previous quarter when the company posted a 458% earnings beat.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

AEHR
Aehr Test Systems

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AEHR News

AEHRAehr Test Systems